ArticleSkin health and disease2026
Teleconsultations for Eczema in CHildren (TECH) feasibility study: a mixed-methods study with adolescents and parents.
Article in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Teleconsultations form a key component of the National Health Service's Long Term Plan, outpatient recovery and -transformation, and commitment to net zero. There is currently little evidence to inform their delivery within paediatric dermatology, a specialty that is increasingly difficult to access. Teleconsultations may offer convenience and widen access for patients, particularly for follow-up of chronic conditions such as eczema. Objectives: To explore patients' and parents' experiences and perceptions of teleconsultations for follow-up of eczema in secondary or tertiary care; to identify components of acceptability of different consultation types and explore how teleconsultations could be optimized; and to obtain views of a potential trial comparing face-to-face appointments with teleconsultations for paediatric eczema follow-up. Methods: A mixed-methods study comprising an online survey and qualitative interviews with patients and parents of children with eczema, who had experience of teleconsultations under secondary or tertiary care, was carried out. An online survey was completed by eligible adolescents and parents. The results informed subsequent semi-structured interviews, conducted with patients and parents, and responses were analysed thematically using framework analysis. Results: Survey responses from 31 parents and 20 adolescents were analysed. Overall, 41% were 'satisfied or very satisfied' following telephone appointments vs. 71% for video and 40% for online or mobile messaging. Preferred consultation type was face-to-face in 67%, with 31% preferring a combination of face-to-face and teleconsultations. Some 41% of participants were interested in participating in a trial comparing face-to-face and teleconsultations for eczema follow-up. Qualitative interviews were conducted with 10 parents and 2 adolescents. Six overarching themes were constructed from the interview data: the value of a dermatology appointment, what is important in an eczema consultation, concerns about patient assessment, complexity of acceptability, patient choice and optimizing teleconsultations. Conclusions: While there was a preference for face-to-face consultations, teleconsultations were acceptable in certain situations, such as for stable eczema or to avoid missing school. Patient perspectives of how teleconsultations could be improved include sending photographs before the appointment and clinician training. This study suggests that directly comparing face-to-face appointments with teleconsultations in a future trial is unlikely to be feasible. A hybrid intervention combining face-to-face and teleconsultation would be more acceptable to patients and parents.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.